Table 2.
Study | Gene | Knockout or Overexpression | Fibre Type Analysis Procedure | Output Measure | Outcome (Relative to Wildtype) |
---|---|---|---|---|---|
[43] | Akirin1 | Knockout | MHC immunofluorescence MHC analysis |
Quadriceps Type 1 | ↓ |
Quadriceps Type 2A | ↑ | ||||
Quadriceps Myh7 1 | ↓ | ||||
Quadriceps Myh2 2A | ↑ | ||||
[44] | Bdkrb2 | Knockout | ATPase staining | Soleus % type 1 | ↑ |
Soleus % type 2A | ↓ | ||||
Soleus % type Intermediary | ↑ | ||||
[45] | Bdnf | Knockout | MHC immunohistochemistry | TA % type 2X | ↑ |
TA % type 2B | ↓ | ||||
EDL % type 2X | ↑ | ||||
EDL % type 2B | ↓ | ||||
[46] | CamK4 | Knockout | MHC immunofluorescence | Soleus % type 1 | ↑ |
Soleus % type 2A | ↓ | ||||
Soleus % type other | ↓ | ||||
[47] | Ccnd3 | Knockout | MHC immunostaining | TA % myofiber type 2A | ↑ |
TA % myofiber type 2B | ↓ | ||||
[48] | Cpt1a | Conditional knockout | MHC immunostaining | TA % type 2A | ↑ |
[49] | FoxJ3 | Knockout | ATPase staining | EDL % type 1 | ↓ |
Soleus % type 1 | ↓ | ||||
[50] | Foxo1 | Overexpression | ATPase staining | Soleus number type 1 | ↓ |
Soleus number type 2 | ↑ | ||||
[51] | Mapk12 | Knockout | MHC immunostaining | Soleus % type 1 | ↑ |
Soleus % type 2A | ↓ | ||||
[52] | Mstn | Knockout | MHC immunostaining | Biceps femoris % type 1 | ↓ |
Biceps femoris % type 2A | ↓ | ||||
Biceps femoris % type 2B/X | ↑ | ||||
TA % type 2A | ↓ | ||||
TA % type 2B/X | ↑ | ||||
[53] | MyoD1 | Knockout | MHC immunohistochemistry | EDL % Type 1 | ↑ |
[54] | Nfatc1 | Conditional knockout | ATPase staining | Soleus number Type 1 | ↓ |
[55] | Nol3 | Knockout | Immunofluorescence MHC | Soleus % type 1 | ↓ |
Soleus % Type 2A | ↑ | ||||
Plantaris % Type 2A | ↓ | ||||
Plantaris % Type 2B | ↑ | ||||
[32] | Ppargc1a | Overexpression | ATPase staining | Plantaris number Type 1 | ↑ |
Plantaris number Type 2A | ↑ | ||||
Plantaris number Type 2B | ↓ | ||||
[56] | Thra | Knockout | ATPase staining | Soleus % Type 1 | ↑ |
Soleus % Type 2A | ↓ | ||||
Thrb | Soleus % Type 1 | ↓ | |||
Soleus % Type 2A | ↑ | ||||
[57] | Epas1 | Conditional Knockout | MHC analysis | Soleus number type 1 | ↓ |
Soleus number type 2B | ↑ | ||||
Soleus MHC 1 | ↓ | ||||
Soleus MHC 2B | ↑ | ||||
[58] | Esrrg | Conditional overexpression | MHC gene expression analysis | Gastrocnemius MHC 2A | ↑ |
Gastrocnemius MHC 2B | ↓ | ||||
[59] | Il15 | Conditional overexpression | MHC gene expression analysis | Soleus MHC 1 | ↑ |
Soleus MHC 2A | ↓ | ||||
Soleus a MHC 2X | ↓ | ||||
EDL MHC 1 | ↑ | ||||
EDL MHC 2X | ↑ | ||||
Gastrocnemius MHC 1 | ↑ | ||||
[60] | Ncor1 | Conditional knockout | MHC gene expression analysis | Gastrocnemius MHC 2A | ↑ |
Gastrocnemius MHC 2X | ↑ | ||||
Quadriceps MHC 1 | ↑ | ||||
Quadriceps MHC 2A | ↑ | ||||
Quadriceps MHC 2X | ↑ | ||||
[61] | Ppargc1b | Conditional overexpression | MHC gene expression analysis | Gastrocnemius MHC 1 | ↓ |
Gastrocnemius MHC 2X | ↑ | ||||
Gastrocnemius MHC 2B | ↓ | ||||
EDL MHC 1 | ↓ | ||||
EDL MHC 2A | ↓ | ||||
EDL MHC 2X | ↑ | ||||
EDL MHC 2B | ↓ | ||||
TA MHC 2A | ↓ | ||||
TA MHC 2X | ↑ | ||||
TA MHC 2B | ↓ | ||||
[62] | Sirt3 | Conditional overexpression | Western blot | Quadriceps MHC 1 | ↑ |
Quadriceps MHC 2B | ↓ | ||||
[63] | Trib3 | Conditional overexpression | Electrophorese of MHC | Soleus MHC 1 | ↑ |
Soleus MHC 2B | ↓ | ||||
TA MHC 2B | ↓ | ||||
[64] | Vgll2 | Knockout | qPCR MHC analysis | Soleus number type 2A | ↓ |
Soleus number type 2B | ↑ | ||||
Soleus Myh7 1 | ↓ | ||||
Soleus Myh2 2A | ↓ | ||||
Soleus Myh1 2X | ↑ | ||||
Soleus Myh4 2B | ↑ | ||||
[65] | Sirt1 | Conditional overexpression | ATPase staining and PCR MHC analysis | Gastrocnemius % Type 1 | ↑ |
Gastrocnemius % Type 2 | ↓ | ||||
Gastrocnemius MHC 2A | ↑ | ||||
Gastrocnemius MHC 2X | ↑ | ||||
Gastrocnemius MHC 2B | ↓ |
Legend ↑ Significantly increased proportion, concentration, or expression when compared to control. ↓ Significantly decreased proportion, concentration, or expression when compared to control. For more detail, see also Table S2 in the supplemental data.